Aclarion, Inc. (NASDAQ:ACONW) Sees Large Increase in Short Interest

Aclarion, Inc. (NASDAQ:ACONW) was the target of a significant growth in short interest during the month of June. As of June 30th, there was short interest totaling 4,580 shares, a growth of 87.3% from the June 15th total of 2,445 shares. Based on an average daily trading volume, of 100,486 shares, the short-interest ratio is currently 0.0 days.

Aclarion Stock Performance

ACONW stock opened at $0.02 on Thursday. The company’s fifty day simple moving average is $0.03 and its 200 day simple moving average is $0.03. Aclarion has a 12-month low of $0.02 and a 12-month high of $0.23.

About Aclarion

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.